Evidence map›Paper›PMID 34631688›Full record

ReviewFrontiers in bioengineering and biotechnology2021

Polymer Scaffolds-Enhanced Bone Regeneration in Osteonecrosis Therapy.

Hengliang Dong, Tongtong Zhu, Mingran Zhang, Dapeng Wang, Xukai Wang, Guanning Huang, Shuaishuai Wang, Minglei Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. 3D-Printed Poly(3-hydroxybutyrate-Biomacromolecules · 2023
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hengliang DongDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Tongtong ZhuDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Mingran ZhangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Dapeng WangDepartment of Orthopedics, Siping Central Hospital, Siping, China.
Xukai WangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Guanning HuangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Shuaishuai WangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Minglei ZhangDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteonecrosis without effective early treatment eventually leads to the collapse of the articular surface and causes arthritis. For the early stages of osteonecrosis, core decompression combined with bone grafting, is a procedure worthy of attention and clinical trial. And the study of bone graft substitutes has become a hot topic in the area of osteonecrosis research. In recent years, polymers have received more attention than other materials due to their excellent performance. However, because of the harsh microenvironment in osteonecrosis, pure polymers may not meet the stringent requirements of osteonecrosis research. The combined application of polymers and various other substances makes up for the shortcomings of polymers, and to meet a broad range of requirements for application in osteonecrosis therapy. This review focuses on various applying polymers in osteonecrosis therapy, then discusses the development of biofunctionalized composite polymers based on the polymers combined with different bioactive substances. At the end, we discuss their prospects for translation to clinical practice.

Indexed as

bone regenerationbone tissue engineeringfunctionalizationosteonecrosis treatmentpolymer scaffold

Identifiers

PMID34631688
PMCPMC8498195
OpenAlexW3203077867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.